Calvo-Gonzalez C, et al. - This study was written with the objective to compare two different initial dosing regimens of intravitreal ranibizumab used to treat myopic choroidal neovascularization. According to the outcome obtained, both dosing regimens led to similar visual outcomes. For eyes given a single injection in the first quarter, retreatment was required appreciably earlier.